Array BioPharma Inc

Type: Company
Name: Array BioPharma Inc
Nationality: United States
Web Address: http://www.arraybiopharma.com/
First reported Jul 28 2014 - Updated Jul 29 2014 - 2 reports

Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014

First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Allergic Rhinitis Market: New Industry Research Report is Now Available for Pre-Order at Transparency Market Research

Allergic Rhinitis is a chronic inflammatory disease of the nasal cavity which causes respiratory problems and affects all age groups. Common symptoms of the disease include sneezing, sore throat, nasal itching and blocked or running nose. The disease ... [Published MyNewsDesk - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing

Related medicine technology :1. Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergans False And Misleading Statements2. 5 things employers should know about prescription painkiller use3. Valeant Pharmaceuticals ... [Published Bio-Medicine - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014

Serco Inc., a ... the Company has been awarded a re-compete contract ... (NEMSCOM) and its Deployable Medical Systems.  Serco will ... personnel to provide world-class healthcare to meet warfighter ... across the globe. The five year contract has ...(Date:7/28/2014)... ... [Published Bio-Medicine - Jul 28 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 3 reports

Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher - Tale of the Tape

Array BioPharma, Inc. ( ARRY ) was a big mover last session, as the company saw its shares rise by nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend ... [Published Zacks.com - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Global concerns temper enthusiasm for earnings

The markets closed mixed with the Dow falling 26 points to 17,086 as concerns about global tensions tempered enthusiasm for corporate earnings. Nasdaq gained 17 points to 4,473.On the upsideSecond quarter earnings fell for Zix ( Nasdaq: ZIXI ) but the ... [Published Good Day Sacramento - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 2 reports

Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

Midway through trading Wednesday, the Dow traded down 0.18 percent to 17,082.38 while the NASDAQ surged 0.41 percent to 4,474.24. The S&P also rose, gaining 0.19 percent to 1,987.23. Leading and Lagging Sectors In trading on Wednesday, healthcare shares ... [Published DailyMe.Com - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped Today

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So What: Neratinib's astronomical success in a phase 3 trial for increasing ... [Published Motley Fool - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 3 reports

WEDNESDAY'S ETF MOVERS : Xbi, soxx

In trading on Wednesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 6.3% on the day. Components of that ETF showing particular strength include shares of Puma Biotechnology (PBYI), up about 291.1% and shares of Array Biopharma ... [Published 4 Traders - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 2 reports

Markets Mixed; PepsiCo Q2 Earnings Beat Street View

Following the market opening Wednesday, the Dow traded down 0.23 percent to 17,073.50 while the NASDAQ surged 0.22 percent to ...Related Stocks:Array Biopharma, Inc. BIOGEN IDEC Inc. Conmed Corp Intuitive Surgical Inc. JUNIPER NETWORKS, Inc. Knightsbridge ... [Published Minyanville - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 23 2014 - 1 reports

Interesting ARRY Put And Call Options For March 2015

Investors in Array BioPharma Inc. (ARRY) saw new options become available this week, for the March 2015 expiration.. ... [Published TVNewsCheck - Jul 22 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Executive Q&A: Nicholas Saccomano, CSO of Array BioPharma

In an interview with The Pharma Letter , Nicholas Saccomano, chief science officer of Array BioPharma (Nasdaq: ARRY), discusses its lead product filanesib, its partnerships with big pharma and why there are many more kinase targets to be discovered.Please ... [Published Pharma Letter - Jul 15 2014]

Quotes

...years and the surrounding communities have been very supportive, so it is with great reluctance that we acknowledge the need to exit," he wrote. "At each site, we are actively engaging in discussions with third-parties about potential future use of the facilities."
"We believe the company is experiencing good pipeline build and business activity from its user conference and the introduction of two new products" he writes...
...Christian Hutter noted the company is delighted to add this leading biopharmaceutical company to its growing base of life sciences customers. "We look forward to helping Array BioPharma meet its strategic goals through this implementation" Hutter added. Junction Solutions supports the production and distribution of pharmaceutical products from planning to execution...

More Content

All (65) | News (32) | Reports (0) | Blogs (26) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
Amgen closing Longmont, Boulder facilities [Published Burlington Record - Jul 30 2014]
Allergic Rhinitis Market: New Industry Research... [Published MyNewsDesk - Jul 29 2014]
All About Crystals: Tiny, Giant, from Mars, fro... [Published Bio-Medicine - Jul 28 2014]
Array BioPharma To Report Financial Results For... [Published Bio-Medicine - Jul 28 2014]
Array BioPharma To Report Financial Results For... [Published Indianapolis Business Journal - Jul 28 2014]
Array BioPharma To Report Financial Results For... [Published PR Newswire: Health - Jul 28 2014]
Array BioPharma, Inc. (ARRY) Jumps: Stock Surge... [Published Zacks.com - Jul 24 2014]
Array BioPharma, Inc. (ARRY) Jumps: Stock Surge... [Published Nasdaq - Jul 24 2014]
Array BioPharma, Inc. (ARRY) Jumps: Stock Surge... [Published Yahoo! Finance - Jul 24 2014]
Alexion Pharmaceuticals EPS Estimates More Opti... [Published Forbes.com - Jul 24 2014]
Global concerns temper enthusiasm for earnings [Published Good Day Sacramento - Jul 23 2014]
Mixed Session, Getting a Little Long in the Tooth [Published Individual.com - Jul 23 2014]
Intuitive Surgical Rises On Upbeat Earnings; Xi... [Published DailyMe.Com - Jul 23 2014]
Intuitive Surgical Rises On Upbeat Earnings; Xi... [Published Minyanville - Jul 23 2014]
Why Oncotheryeon, Inc., OncoMed Pharmaceuticals... [Published Motley Fool - Jul 23 2014]
WEDNESDAY'S ETF MOVERS : Xbi, soxx [Published 4 Traders - Jul 23 2014]
Wednesday's ETF Movers: XBI, SOXX [Published Forbes.com - Jul 23 2014]
Wednesday's ETF Movers: XBI, SOXX [Published Atlanta Journal And Constitution - Jul 23 2014]
BUZZ-U.S. Stocks on the Move-Apple, Microsoft, ... [Published London South East - Jul 23 2014]
Markets Mixed; PepsiCo Q2 Earnings Beat Street ... [Published Minyanville - Jul 23 2014]
Markets Mixed; PepsiCo Q2 Earnings Beat Street ... [Published Benzinga.com - Jul 23 2014]
Array Biopharma Up 14.9%, Shares Break Through ... [Published Individual.com - Jul 23 2014]
Interesting ARRY Put And Call Options For March... [Published TVNewsCheck - Jul 22 2014]
Wall Street Sees Massive Upside In These 3 Litt... [Published StreetAuthority - Jul 17 2014]
Executive Q&A: Nicholas Saccomano, CSO of Array... [Published Pharma Letter - Jul 15 2014]
Biotech Stocks Highlight -- Research on Celgene... [Published Financial Services - Jul 09 2014]
Study Updates, Market Activity, Preclinical Dat... [Published Pettinga Financial Advisors - Jul 03 2014]
Study Updates, Market Activity, Preclinical Dat... [Published Financial Services - Jul 03 2014]
Array BioPharma To Present At The Wells Fargo S... [Published PR Newswire: General Business - Jun 11 2014]
Health Care Sector Equities Coverage -- Researc... [Published Financial Services - Jun 06 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Array BioPharma To Report Financial Results For... [Published PR Newswire: Health - Jul 28 2014]
BOULDER, Colo., July 28, 2014  Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the fourth quarter and full year of fiscal 2014 and hold a conference call to discuss those results on Tuesday, August 12, 2014.  Ron Squarer, Chief ...
Array BioPharma To Present At The Wells Fargo S... [Published PR Newswire: General Business - Jun 11 2014]
BOULDER, Colo., June 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities 2014 Healthcare Conference in Boston.  The public is welcome ...
Frontrunning: May 30 [Published Zero Hedge - May 30 2014]
Ukraine Rebels Outfox Army to Dent Poroshenko Troop Goal ( BBG ) Russia Withdraws Most of Forces From Ukraine Border: U.S. ( BBG ) Super-Size Me! China’s ’Mini’ Stimulus Starts Expanding ( BBG ) Option B: The blueprint for Thailand's coup ( Reuters ) ...
Array BioPharma, Biogen Idec enter drug discove... [Published PBR - News - May 29 2014]
US-based biopharmaceutical firm Array BioPharma has entered into collaboration agreement with Biogen Idec to discover and develop inhibitors targeting a new kinase for the treatment of autoimmune disorders. ...
Array BioPharma Announces Drug Discovery Collab... [Published PR Newswire: Health - May 28 2014]
BOULDER, Colo., May 28, 2014 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) announced today a collaboration agreement with Biogen Idec (NASDAQ: BIIB) for the discovery and development of inhibitors targeting a novel kinase for the treatment of autoimmune ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Biotech Stocks Highlight -- Research on Celgene... [Published Financial Services - Jul 09 2014]
Study Updates, Market Activity, Preclinical Dat... [Published Financial Services - Jul 03 2014]
Health Care Sector Equities Coverage -- Researc... [Published Financial Services - Jun 06 2014]
Top Gainers Technical Data -- Research on BioSc... [Published Financial Services - May 12 2014]
Biotech Stocks Analysis -- Research on Array Bi... [Published Financial Services - Mar 28 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.